Original Article
A nomogram prognostic model for large cell lung cancer: analysis from the Surveillance, Epidemiology and End Results Database
Translational Lung Cancer Research
2021;
10
(2)
:622-635
.
(28 February 2021)
Comprehensive genomic profiling of combined small cell lung cancer
Translational Lung Cancer Research
2021;
10
(2)
:636-650
.
(28 February 2021)
Hyponatremia as a prognostic factor in non-small cell lung cancer: a systematic review and meta-analysis
Translational Lung Cancer Research
2021;
10
(2)
:651-661
.
(28 February 2021)
EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study
Translational Lung Cancer Research
2021;
10
(2)
:662-674
.
(28 February 2021)
The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation
Translational Lung Cancer Research
2021;
10
(2)
:675-684
.
(28 February 2021)
PD-1 restrains IL-17A production from γδ T cells to modulate acute radiation-induced lung injury
Translational Lung Cancer Research
2021;
10
(2)
:685-698
.
(28 February 2021)
Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma
Translational Lung Cancer Research
2021;
10
(2)
:699-711
.
(28 February 2021)
Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001
Translational Lung Cancer Research
2021;
10
(2)
:712-722
.
(28 February 2021)
Feasibility of implementing a national lung cancer screening program: Interim results from the Korean Lung Cancer Screening Project (K-LUCAS)
Translational Lung Cancer Research
2021;
10
(2)
:723-736
.
(28 February 2021)
KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma
Translational Lung Cancer Research
2021;
10
(2)
:737-752
.
(28 February 2021)
Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations
Translational Lung Cancer Research
2021;
10
(2)
:753-765
.
(28 February 2021)
Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung
Translational Lung Cancer Research
2021;
10
(2)
:766-775
.
(28 February 2021)
Novel risk scoring system for immune checkpoint inhibitors treatment in non-small cell lung cancer
Translational Lung Cancer Research
2021;
10
(2)
:776-789
.
(28 February 2021)
Vimentin expression status is a potential biomarker for brain metastasis development in EGFR-mutant NSCLC patients
Translational Lung Cancer Research
2021;
10
(2)
:790-801
.
(28 February 2021)
An immune-related gene expression signature predicts brain metastasis in lung adenocarcinoma patients after surgery: gene expression profile and immunohistochemical analyses
Translational Lung Cancer Research
2021;
10
(2)
:802-814
.
(28 February 2021)
A large real-world cohort study of examined lymph node standards for adequate nodal staging in early non-small cell lung cancer
Translational Lung Cancer Research
2021;
10
(2)
:815-825
.
(28 February 2021)
Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients
Translational Lung Cancer Research
2021;
10
(2)
:826-838
.
(28 February 2021)
Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II study
Translational Lung Cancer Research
2021;
10
(2)
:839-854
.
(28 February 2021)
The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancer
Translational Lung Cancer Research
2021;
10
(2)
:855-865
.
(28 February 2021)
Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer
Translational Lung Cancer Research
2021;
10
(2)
:866-877
.
(28 February 2021)
Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors
Translational Lung Cancer Research
2021;
10
(2)
:878-888
.
(28 February 2021)
Apatinib with etoposide capsules as a third- or further-line therapy for extensive-stage small cell lung cancer: an open-label, multicenter, single-arm phase II trial
Translational Lung Cancer Research
2021;
10
(2)
:889-899
.
(28 February 2021)
Segmental resection is associated with decreased survival in patients with stage IA non-small cell lung cancer with a tumor size of 21–30 mm
Translational Lung Cancer Research
2021;
10
(2)
:900-913
.
(28 February 2021)
Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis
Translational Lung Cancer Research
2021;
10
(2)
:914-925
.
(28 February 2021)
Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer
Translational Lung Cancer Research
2021;
10
(2)
:926-935
.
(28 February 2021)
TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis
Translational Lung Cancer Research
2021;
10
(2)
:936-954
.
(28 February 2021)
A machine learning-based prediction of the micropapillary/solid growth pattern in invasive lung adenocarcinoma with radiomics
Translational Lung Cancer Research
2021;
10
(2)
:955-964
.
(28 February 2021)
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma
Translational Lung Cancer Research
2021;
10
(2)
:965-980
.
(28 February 2021)
Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification
Translational Lung Cancer Research
2021;
10
(2)
:981-994
.
(28 February 2021)
Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study
Translational Lung Cancer Research
2021;
10
(2)
:995-1006
.
(28 February 2021)
Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma
Translational Lung Cancer Research
2021;
10
(2)
:1007-1019
.
(28 February 2021)
Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study
Translational Lung Cancer Research
2021;
10
(2)
:1020-1028
.
(28 February 2021)
Review Article
The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review
Translational Lung Cancer Research
2021;
10
(2)
:1029-1038
.
(28 February 2021)
Case Report
Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report
Translational Lung Cancer Research
2021;
10
(2)
:1039-1046
.
(28 February 2021)
Editorial on Implementation of CT-based Screening of Lung Cancer1
Editorial on implementation of CT-based screening of lung cancer
Translational Lung Cancer Research
2021;
10
(2)
:1047-1049
.
(28 February 2021)
Review Article on Implementation of CT-based Screening of Lung Cancer1
Implementation of lung cancer screening: what are the main issues?
Translational Lung Cancer Research
2021;
10
(2)
:1050-1063
.
(28 February 2021)
Implementation of low-dose CT screening in two different health care systems: Mount Sinai Healthcare System and Phoenix VA Health Care System
Translational Lung Cancer Research
2021;
10
(2)
:1064-1082
.
(28 February 2021)
Original Article on Implementation of CT-based Screening of Lung Cancer1
Performance of various risk prediction models in a large lung cancer screening cohort in Gdańsk, Poland—a comparative study
Translational Lung Cancer Research
2021;
10
(2)
:1083-1090
.
(28 February 2021)
Review Article on Implementation of CT-based Screening of Lung Cancer1
Participation in lung cancer screening
Translational Lung Cancer Research
2021;
10
(2)
:1091-1098
.
(28 February 2021)
Lung cancer screening and smoking cessation efforts
Translational Lung Cancer Research
2021;
10
(2)
:1099-1109
.
(28 February 2021)
A narrative review of invasive diagnostics and treatment of early lung cancer
Translational Lung Cancer Research
2021;
10
(2)
:1110-1123
.
(28 February 2021)
Pulmonary nodule radiological diagnostic algorithm in lung cancer screening
Translational Lung Cancer Research
2021;
10
(2)
:1124-1135
.
(28 February 2021)
Overdiagnosis in lung cancer screening
Translational Lung Cancer Research
2021;
10
(2)
:1136-1140
.
(28 February 2021)
Added benefits of early detection of other diseases on low-dose CT screening
Translational Lung Cancer Research
2021;
10
(2)
:1141-1153
.
(28 February 2021)
Latest CT technologies in lung cancer screening: protocols and radiation dose reduction
Translational Lung Cancer Research
2021;
10
(2)
:1154-1164
.
(28 February 2021)
Molecular biomarkers in early stage lung cancer
Translational Lung Cancer Research
2021;
10
(2)
:1165-1185
.
(28 February 2021)
Radiomics and artificial intelligence in lung cancer screening
Translational Lung Cancer Research
2021;
10
(2)
:1186-1199
.
(28 February 2021)
Disclosure:
1. The series “Implementation of CT-based screening of lung cancer” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Witold Rzyman served as the unpaid Guest Editor for the series.
